Suppression of bone formation by osteoclastic expression of semaphorin 4D
about
The osteocyte: key player in regulating bone turnoverBiology of Bone Tissue: Structure, Function, and Factors That Influence Bone CellsBone cell communication factors and SemaphorinsArhgap28 is a RhoGAP that inactivates RhoA and downregulates stress fibersBone Cells Dynamics during Peri-Implantitis: a Theoretical AnalysisDifferential mechanisms of de-regulated bone formation in rheumatoid arthritis and spondyloarthritisCoupling Signals between the Osteoclast and Osteoblast: How are Messages Transmitted between These Temporary Visitors to the Bone Surface?Mice Deficient in AKAP13 (BRX) Are Osteoporotic and Have Impaired OsteogenesisThe Crosstalk between Osteoclasts and Osteoblasts Is Dependent upon the Composition and Structure of Biphasic Calcium PhosphatesMicroRNA-433-3p promotes osteoblast differentiation through targeting DKK1 expressionProstaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.Osteoclasts: more than 'bone eaters'.The IκB kinase complex is required for plexin-B-mediated activation of RhoAFactors and mechanisms involved in the coupling from bone resorption to formation: how osteoclasts talk to osteoblasts.Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts.Kruppel-like factor 4 expression in osteoblasts represses osteoblast-dependent osteoclast maturation.Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis.Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model.Increased levels of plasma soluble Sema4D in patients with heart failure.Effect of (-)-epigallocatechin-3-gallate in preventing bone loss in ovariectomized rats and possible mechanisms.Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategyPrevention of alveolar bone loss in an osteoporotic animal model via interference of semaphorin 4dProgranulin and a five transmembrane domain-containing receptor-like gene are the key components in receptor activator of nuclear factor κB (RANK)-dependent formation of multinucleated osteoclastsArachidonic acid enhances turnover of the dermal skeleton: studies on zebrafish scales.Pharmacological Inhibition of Protein Kinase G1 Enhances Bone Formation by Human Skeletal Stem Cells Through Activation of RhoA-Akt Signaling.IGF-1 Signaling is Essential for Differentiation of Mesenchymal Stem Cells for Peak Bone Mass.Semaphorin 4D Promotes Skeletal Metastasis in Breast CancerOsteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.Potential role of odanacatib in the treatment of osteoporosis.Estrogen and the skeletonSerum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosisStimulation of Osteogenesis in Bone Defects Implanted with Biodegradable Hydroxyapatite Composed of Rod-Shaped Particles under Mechanical Unloading.Netrin-1 is a critical autocrine/paracrine factor for osteoclast differentiationBone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases.Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts.Bone marrow mesenchymal stem cells: fat on and blast off by FGF21A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formationIL-17-producing γδ T cells enhance bone regeneration.Ciliary IFT80 balances canonical versus non-canonical hedgehog signalling for osteoblast differentiation
P2860
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
P248
Q26777912-DFEDBB17-0C6E-4DD3-A228-6774EE01C803Q26801599-0FED2A9A-C7CD-49FC-8A69-4EE07684E4B3Q27023494-8208F0EE-ED98-455F-9389-8D3ED235E7F0Q27348870-8139B508-C79D-4381-B63F-3C70655BB4CCQ28066397-893FACCF-4E3A-4A48-9BA0-EA6755CC9BB3Q28073386-8902C1C8-FCAE-4A5E-B997-68B85AD5BA79Q28083559-54E2EB95-97A8-4C09-A553-929C9EEA15DEQ28511561-06F722DD-A42E-4EE7-9F55-18FC85FAC4E3Q28546666-EBF6158B-23AA-4099-9BDF-C157DE3F9F35Q33811916-4A7FF852-C580-4171-B714-E0D097668E35Q33814310-2A741324-61D6-489F-B080-376B2106D50CQ33993757-6F41EDEE-137F-461F-B90E-1024B39A5E8CQ34066731-A657B0BF-AC5C-4420-93DC-2FA81F3FC589Q34219161-5D44CCB3-4CE8-4BEB-803A-302F0A850219Q34383078-00DE5B46-02BB-4E0B-8C71-7C767ED95563Q34424720-6C403609-B2FE-4442-A116-0CFA606C0B58Q34487793-80356FEA-A39C-4EFA-A795-46747636DD47Q34551206-3DECA380-C3C7-43CA-93A2-81D3FCA2C705Q34760436-8FE608A7-8632-434A-B253-ED8B68F18097Q34769905-2AE36805-4CC4-4B62-A1DD-0D13F19A2E5AQ34902134-C23FE3DE-F0A1-43DE-B5AA-AA76AE5D7B35Q34950479-EE937245-593D-4BC3-A722-1B5AF0ABD335Q35002815-F51A8BC0-5EF0-46B5-B140-375CBB8FD431Q35107103-9DDC6B54-874A-49DC-88D7-9C4FDE1EA1AAQ35598732-32A5D00C-A3AF-43A8-B45C-33F3FDFE0A51Q35755073-193376E6-CC33-427A-9DC2-A21A95E38E42Q35933921-69B859E4-438A-45B2-AACE-4C77BF948355Q36040583-040E5B9C-4149-43E9-B1A8-DFD8A4DEA494Q36136239-192F5A09-423F-46B4-9A05-F744B0285D03Q36179747-706C1788-13F5-484E-884E-26F3BFA2DA56Q36317974-C5F7CF73-EE3F-4509-992D-583DE82EC257Q36395303-F8F8D707-1FB6-45E0-B649-DC41616A71BBQ36399152-D52A1103-AADE-4EC8-BB02-53A8105AD66AQ36402724-681E7584-591B-4922-8B1E-A8CD14E17D0DQ36594661-67FB077C-FC1F-46F3-AE84-8AFDF46F59F2Q36597639-9EA10DAF-CBD3-4A5C-8B86-BFB17A0BFDA2Q36617953-E95CC65E-C6A2-49C5-8F4C-D9E46DA6AD85Q36674531-CE1A95C2-7BDB-45FE-9BED-59E7BD79BC1BQ36690217-AFEAD967-43DF-4E07-AB8A-B10BF0932D1AQ36713352-7F6983A0-C60F-4903-84EE-A71D4C8E3100
P2860
Suppression of bone formation by osteoclastic expression of semaphorin 4D
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@ast
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@en
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@en-gb
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@nl
type
label
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@ast
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@en
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@en-gb
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@nl
prefLabel
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@ast
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@en
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@en-gb
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Suppression of bone formation by osteoclastic expression of semaphorin 4D
@en
P2093
Haruhiko Bito
Hiroshi Takayanagi
Noriko Komatsu
Takako Negishi-Koga
Tatsuhiko Kodama
P2860
P2888
P304
P3181
P356
10.1038/NM.2489
P407
P577
2011-10-23T00:00:00Z
P5875
P6179
1051638712